Found: 136
Select item for more details and to access through your institution.
Dual targeting of EGFR and HER-2 in colon cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 973, doi. 10.1007/s00280-008-0820-9
- By:
- Publication type:
- Article
Lack of toxicity of a STAT3 decoy oligonucleotide.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 983, doi. 10.1007/s00280-008-0823-6
- By:
- Publication type:
- Article
Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 997, doi. 10.1007/s00280-008-0830-7
- By:
- Publication type:
- Article
Studies of structure–activity relationship on plant polyphenol-induced suppression of human liver cancer cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1007, doi. 10.1007/s00280-008-0802-y
- By:
- Publication type:
- Article
Successful re-challenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1017, doi. 10.1007/s00280-008-0831-6
- By:
- Publication type:
- Article
Growth inhibitory activity of a novel lectin from Cliona varians against K562 human erythroleukemia cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1023, doi. 10.1007/s00280-008-0825-4
- By:
- Publication type:
- Article
Multiple-pool cell lifespan models for neutropenia to assess the population pharmacodynamics of unbound paclitaxel from two formulations in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1035, doi. 10.1007/s00280-008-0828-1
- By:
- Publication type:
- Article
Mechanistic population pharmacokinetics of total and unbound paclitaxel for a new nanodroplet formulation versus Taxol in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1049, doi. 10.1007/s00280-008-0827-2
- By:
- Publication type:
- Article
Phase I study of cetuximab, erlotinib, and bevacizumab in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1065, doi. 10.1007/s00280-008-0811-x
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of mitomycin C and celecoxib as potential modulators of tumor resistance to irinotecan in patients with solid malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1073, doi. 10.1007/s00280-008-0826-3
- By:
- Publication type:
- Article
A multi-center phase II study of S-1 plus paclitaxel as first-line therapy for patients with advanced or recurrent unresectable gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1083, doi. 10.1007/s00280-008-0818-3
- By:
- Publication type:
- Article
Cisplatin and weekly docetaxel with concurrent thoracic radiotherapy for locally advanced stage III non-small-cell lung cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1091, doi. 10.1007/s00280-008-0837-0
- By:
- Publication type:
- Article
Experiences and practical conclusions concerning temsirolimus use and adverse event management in advanced renal cell carcinoma within a compassionate use program in Germany.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1097, doi. 10.1007/s00280-008-0835-2
- By:
- Publication type:
- Article
Role of BCRP as a biomarker for predicting resistance to 5-fluorouracil in breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1103, doi. 10.1007/s00280-008-0838-z
- By:
- Publication type:
- Article
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1111, doi. 10.1007/s00280-008-0834-3
- By:
- Publication type:
- Article
Diverse cross-resistance phenotype to ET-743 and PM00104 in multi-drug resistant cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1121, doi. 10.1007/s00280-008-0843-2
- By:
- Publication type:
- Article
Cytotoxic diarylheptanoid induces cell cycle arrest and apoptosis via increasing ATF3 and stabilizing p53 in SH-SY5Y cells.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1131, doi. 10.1007/s00280-008-0832-5
- By:
- Publication type:
- Article
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1141, doi. 10.1007/s00280-008-0839-y
- By:
- Publication type:
- Article
A phase I study of Triapine in combination with doxorubicin in patients with advanced solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- journal article
A phase I study of Triapine<sup>®</sup> in combination with doxorubicin in patients with advanced solid tumors.
- Published in:
- 2009
- By:
- Publication type:
- Report
Extended survival of a HER-2-positive metastatic breast cancer patient with brain metastases also treated with intrathecal trastuzumab.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1157, doi. 10.1007/s00280-008-0859-7
- By:
- Publication type:
- Article
Isolated molecular relapse in FIP1L1-PDGFRalpha hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Isolated molecular relapse in FIP1L1-PDGFRα hypereosinophilic syndrome after discontinuation and single weekly dose of imatinib: need of quantitative molecular procedures to modulate imatinib dose.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1161, doi. 10.1007/s00280-008-0858-8
- By:
- Publication type:
- Article
Life-threatening toxicities in a patient with UGT1A1*6/*28 and SLCO1B1*15/*15 genotypes after irinotecan-based chemotherapy.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Life-threatening toxicities in a patient with UGT1A1* 6/* 28 and SLCO1B1* 15/* 15 genotypes after irinotecan-based chemotherapy.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1165, doi. 10.1007/s00280-008-0864-x
- By:
- Publication type:
- Article
Lenalidomide: in vitro evaluation of the metabolism and assessment of cytochrome P450 inhibition and induction.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1171, doi. 10.1007/s00280-008-0867-7
- By:
- Publication type:
- Article
Early severe toxicities after capecitabine intake: possible implication of a cytidine deaminase extensive metabolizer profile.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 6, p. 1177, doi. 10.1007/s00280-008-0889-1
- By:
- Publication type:
- Article
5-FU pretreatment potentiates cisplatin-induced apoptosis through up-regulation of thrombospondin-1 in head and neck squamous cell carcinomas.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Central and peripheral nervous system toxicity of common chemotherapeutic agents.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 761, doi. 10.1007/s00280-008-0876-6
- By:
- Publication type:
- Article
Growth inhibition of hepatocellular carcinoma cells in vitro and in vivo by the 8-methoxy analog of WMC79.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 769, doi. 10.1007/s00280-008-0801-z
- By:
- Publication type:
- Article
Uncontrolled hypertriglyceridemia induced by capecitabine: case report and review of the literature.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 779, doi. 10.1007/s00280-008-0799-2
- By:
- Publication type:
- Article
Dependence on PI3K/Akt signaling for malignant rhabdoid tumor cell survival.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 783, doi. 10.1007/s00280-008-0796-5
- By:
- Publication type:
- Article
Phase II study of 9-aminocamptothecin in previously treated lymphomas: results of Cancer and Leukemia Group B 9551.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 793, doi. 10.1007/s00280-008-0803-x
- By:
- Publication type:
- Article
A pharmacologic analysis of intraoperative intracavitary cancer chemotherapy with doxorubicin.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 799, doi. 10.1007/s00280-008-0800-0
- By:
- Publication type:
- Article
Characterization of kinase suppressor of Ras-1 expression and anticancer drug sensitivity in human cancer cell lines.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 807, doi. 10.1007/s00280-008-0794-7
- By:
- Publication type:
- Article
A multiple-center phase II study of biweekly oxaliplatin and tegafur-uracil/leucovorin for chemonaive patients with advanced gastric cancer.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
A multiple-center phase II study of biweekly oxaliplatin and tegafur–uracil/leucovorin for chemonaive patients with advanced gastric cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 819, doi. 10.1007/s00280-008-0797-4
- By:
- Publication type:
- Article
A model-based approach to the in vitro evaluation of anticancer activity.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 827, doi. 10.1007/s00280-008-0798-3
- By:
- Publication type:
- Article
Role of RNase L in apoptosis induced by 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine.
- Published in:
- 2009
- By:
- Publication type:
- Journal Article
Role of RNase L in apoptosis induced by 1-(3- C-ethynyl-β- d- ribo-pentofuranosyl)cytosine.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 837, doi. 10.1007/s00280-008-0810-y
- By:
- Publication type:
- Article
A multi-center phase II study of oxaliplatin, irinotecan, and capecitabine in advanced gastric/gastroesophageal junction carcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 851, doi. 10.1007/s00280-008-0807-6
- By:
- Publication type:
- Article
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 859, doi. 10.1007/s00280-008-0805-8
- By:
- Publication type:
- Article
Predictive factors for efficacy of capecitabine in heavily pretreated patients with metastatic breast cancer.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 865, doi. 10.1007/s00280-008-0806-7
- By:
- Publication type:
- Article
Protective effect of aged garlic extract (AGE) on the apoptosis of intestinal epithelial cells caused by methotrexate.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 873, doi. 10.1007/s00280-008-0809-4
- By:
- Publication type:
- Article
The Werner's syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The Werner’s syndrome 4330T>C (Cys1367Arg) gene variant does not affect the in vitro cytotoxicity of topoisomerase inhibitors and platinum compounds.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 881, doi. 10.1007/s00280-008-0793-8
- By:
- Publication type:
- Article
Effect of phenazine compounds XR11576 and XR5944 on DNA topoisomerases.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 889, doi. 10.1007/s00280-008-0812-9
- By:
- Publication type:
- Article
A phase I and pharmacokinetic study of paclitaxel poliglumex and cisplatin in patients with advanced solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 903, doi. 10.1007/s00280-008-0813-8
- By:
- Publication type:
- Article
The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 911, doi. 10.1007/s00280-008-0815-6
- By:
- Publication type:
- Article
Postoperative adjuvant chemotherapy of gastric cancer: scrutiny into the clinical evidence based on quality assessment of medical literature of randomized controlled trials.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2009, v. 63, n. 5, p. 919, doi. 10.1007/s00280-008-0808-5
- By:
- Publication type:
- Article